MEIP : Summary for MEI Pharma, Inc. - Yahoo Finance

U.S. Markets closed

MEI Pharma, Inc. (MEIP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.580.00 (0.00%)
At close: 4:00 PM EST
People also watch:
OHRPCNATATNMVSTMACRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.58
Open1.60
Bid1.56 x 100
Ask1.69 x 17000
Day's Range1.58 - 1.65
52 Week Range0.87 - 2.28
Volume684,932
Avg. Volume244,563
Market Cap58.1M
Beta2.21
PE Ratio (TTM)-2.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire16 days ago

    MEI Pharma to Host Annual Meeting of Stockholders

    SAN DIEGO, Nov. 17, 2016 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, will host its Annual Meeting of Stockholders at 10:00 a.m. Pacific time on Thursday, December 1, 2016, at the Company's headquarters, located at 11975 El Camino Real, Suite 101, San Diego, CA 92130. Stockholders of record at the close of business on October 5, 2016 are entitled to receive notice of and vote at the Annual Meeting. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

  • PR Newswire25 days ago

    MEI Pharma Reports First Quarter Fiscal Year 2017 Results

    SAN DIEGO, Nov. 9, 2016 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its first quarter ...

  • PR Newswire26 days ago

    MEI Pharma to Present at Stifel Healthcare Conference

    SAN DIEGO, Nov. 7, 2016 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Stifel Healthcare Conference on Tuesday, November 15, 2016 at 3:45 p.m. Eastern time from the Lotte New York Palace Hotel. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.